← back to search

Manasi K. Mayekar

University of California, San Francisco · US
Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include RNA Research and Splicing, RNA modifications and cancer, Genomics and Chromatin Dynamics, and Lung Cancer Treatments and Mutations.
h-index
12
citations
882
works
28
NIH funding
primary concept
email

Recent publications

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance
Nature Genetics 2023cited by 85position: middledoi
Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer
Journal of Clinical Investigation 2022cited by 53position: middledoi
Editorial: Metabolism and Epigenetics
Frontiers in Genetics 2022cited by 6position: middledoi
Betacellulin drives therapy resistance in glioblastoma
Neuro-Oncology 2019cited by 12position: middledoi
Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion Proteins
Cancer Research 2018cited by 96position: middledoi
Current Landscape of Targeted Therapy in Lung Cancer
Clinical Pharmacology & Therapeutics 2017cited by 185position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Trever G. Bivona · UCSF Helen Diller Family Comprehensive Cancer Center3 papers (2017–2019)Franziska Haderk · Boehringer Ingelheim (Germany)1 papers (2019–2019)Edbert D Lu · University of California, San Francisco1 papers (2019–2019)Krishna Seshu Tummala · Center for Cancer Research1 papers (2022–2022)Dana S. Neel · Boston Children's Hospital1 papers (2018–2018)Victor Olivas · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2018–2018)David V. Allegakoen · Georgetown University1 papers (2018–2018)William A. Weiss · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2019–2019)Robyn A. Wong · City Of Hope National Medical Center1 papers (2019–2019)Kevan M. Shokat · Howard Hughes Medical Institute1 papers (2019–2019)Jonathan W. Riess · UC Davis Children's Hospital1 papers (2018–2018)Niki Karachaliou · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2018–2018)Anh T. Le · University of Colorado Cancer Center1 papers (2018–2018)Qi‐Wen Fan · University of California, San Francisco1 papers (2019–2019)Nilanjana Chatterjee · University of California, San Francisco1 papers (2018–2018)Robert J. Nichols · Palo Alto University1 papers (2018–2018)Zhenyi An · Broad Institute1 papers (2019–2019)Indrabahadur Singh · Heidelberg University1 papers (2022–2022)Julia Rotow · Harvard University1 papers (2018–2018)Collin M. Blakely · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2018–2018)